Whole-Exome Sequencing Identified a Novel Variant (C.405_422+39del) in
Desmoplakin
Dilated cardiomyopathy
Pathogenic variant
Whole exome sequencing
Journal
Reports of biochemistry & molecular biology
ISSN: 2322-3480
Titre abrégé: Rep Biochem Mol Biol
Pays: Iran
ID NLM: 101637937
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
30
01
2021
accepted:
13
02
2021
entrez:
4
10
2021
pubmed:
5
10
2021
medline:
5
10
2021
Statut:
ppublish
Résumé
Dilated cardiomyopathy (DCM) is a progressive heart condition characterized by left ventricular chamber enlargement associated with systolic heart failure and prolonged action potential duration. Genetic variations in genes that encode cytoskeleton, sarcomere, and nuclear envelope proteins are responsible for 45% of cases. In our study, we focused on a pedigree with familial DCM to decipher the potential genetic cause(s) in affected members developing arrhythmia, end-stage heart failure, and sudden death. Whole-exome sequencing (WES) was exploited for a 27-year-old heart-transplanted female as the proband, and the derived data were filtered using the standard pipelines. A 57-nucleotide deletion (c.405_422+39del) in the desmoplakin gene (DSP) (NM_004415.4) was identified as a novel pathogenic variant. Familial segregation analysis indicated that this variant is present in clinically affected members and absent in unaffected members. It seems that the detected variant induces intron retention, resulting in a premature stop codon in intron 3 of DSP leading to production of a truncated, nonfunctional protein. Additionally, it can trigger a nonsense-mediated mRNA decay pathway associated with inhibition of protein production. The present study results illustrated that a novel deletion in DSP can cause DCM in an Iranian family.
Sections du résumé
BACKGROUND
BACKGROUND
Dilated cardiomyopathy (DCM) is a progressive heart condition characterized by left ventricular chamber enlargement associated with systolic heart failure and prolonged action potential duration. Genetic variations in genes that encode cytoskeleton, sarcomere, and nuclear envelope proteins are responsible for 45% of cases. In our study, we focused on a pedigree with familial DCM to decipher the potential genetic cause(s) in affected members developing arrhythmia, end-stage heart failure, and sudden death.
METHODS
METHODS
Whole-exome sequencing (WES) was exploited for a 27-year-old heart-transplanted female as the proband, and the derived data were filtered using the standard pipelines.
RESULTS
RESULTS
A 57-nucleotide deletion (c.405_422+39del) in the desmoplakin gene (DSP) (NM_004415.4) was identified as a novel pathogenic variant. Familial segregation analysis indicated that this variant is present in clinically affected members and absent in unaffected members.
CONCLUSION
CONCLUSIONS
It seems that the detected variant induces intron retention, resulting in a premature stop codon in intron 3 of DSP leading to production of a truncated, nonfunctional protein. Additionally, it can trigger a nonsense-mediated mRNA decay pathway associated with inhibition of protein production. The present study results illustrated that a novel deletion in DSP can cause DCM in an Iranian family.
Identifiants
pubmed: 34604417
doi: 10.52547/rbmb.10.2.280
pii: rbmb-10-280
pmc: PMC8480302
doi:
Types de publication
Journal Article
Langues
eng
Pagination
280-287Références
J Cell Biol. 1998 Jun 1;141(5):1229-41
pubmed: 9606214
Lancet. 2017 Jul 22;390(10092):400-414
pubmed: 28190577
J Am Coll Cardiol. 2016 Jun 28;67(25):2996-3010
pubmed: 27339497
Discov Med. 2013 Jan;15(80):43-9
pubmed: 23375013
Curr Opin Cardiol. 2012 May;27(3):214-20
pubmed: 22421630
Eur Heart J. 2015 May 7;36(18):1123-35a
pubmed: 25163546
Am J Hum Genet. 2002 Nov;71(5):1200-6
pubmed: 12373648
Heart. 2000 Jul;84(1):106-12
pubmed: 10862601
Circulation. 2006 Apr 11;113(14):1807-16
pubmed: 16567565
Clin Genet. 2013 Jul;84(1):20-30
pubmed: 23137101
J Am Heart Assoc. 2015 Dec 09;4(12):
pubmed: 26656454
Circ Res. 2017 Sep 15;121(7):731-748
pubmed: 28912180
Nat Rev Cardiol. 2013 Sep;10(9):531-47
pubmed: 23900355
Eur Heart J. 2008 Jan;29(2):270-6
pubmed: 17916581
Genet Med. 2010 Nov;12(11):655-67
pubmed: 20864896
J Med Genet. 2011 Sep;48(9):580-9
pubmed: 21730106
Eur Heart J. 2010 Nov;31(22):2715-26
pubmed: 20823110
Eur Heart J. 2005 Aug;26(16):1666-75
pubmed: 15941723
BMC Med Genet. 2020 Jan 31;21(1):19
pubmed: 32005173
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239
pubmed: 23747642
Biochim Biophys Acta. 2008 Mar;1778(3):572-87
pubmed: 17854763
J Am Coll Cardiol. 2012 Jul 24;60(4):283-9
pubmed: 22813604
Eur Heart J. 2016 Jun 14;37(23):1850-8
pubmed: 26792875